Vironix remote physiological monitoring & disease-specific AI intelligence for respiratory and cardiovascular chronic illnesses
Either you or someone you know has been impacted by heart or lung disease.
17.9 MILLION PEOPLE
die each year from cardiovascular disease.
That’s one death every 56 seconds.
People diagnosed with or at risk of heart failure, COPD, asthma, & acute respiratory illness face constant risk of death, hospitalization, massive healthcare expenditures, and persistent anxiety. If detected and managed early, singular health deterioration episodes, which include exacerbations & infections, can be readily addressed at home with diet, medications, and rest.
is the cost of preventable heart and lung disease to employers and health insurance providers
Peer-Reviewed, World Class R&D
Clinically validated algorithms built by scientists and clinicians.
Vironix Health to Deploy Remote Therapeutic Monitoring Capability in The Vancouver Clinic's Transitional Care Team
The Vancouver Clinic (TVC) is utilizing Vironix Health’s AI-Enabled Remote Patient Care Products to Combat Preventable Heart Disease Hospitalizations in Vancouver, WA
2022 OPTIMIZE Conference
Vironix Health team members, Sumanth Swaminathan, Botros Toro, and Chris Landon participated in the 2022 OPTIMIZE Conference held Sept 21st-22nd at the historic Churchill Downs. After the team members gave their invited talk as one of 8 global innovation search finalists in the Aging2.0 competition, they presented the winning trophy in a horse race named after Vironix Health!!
Vironix Health has teamed up with Oxford University
Exciting new research partnership: Vironix Health has teamed up with Oxford University to develop novel prediction methods for proactive intervention on Congestive Heart Failure.
Vironix was formed by passionate scientists, physicians, technologists, and entrepreneurs who have amassed decades of research, development, and commercialization expertise in the development, testing, and commercialization of medical technology.